STAT

Join STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The pandemic caused by the novel coronavirus has shut down countries around...

Join STAT for a three-part digital event series covering the race for new medicines that will impact Covid-19. The pandemic caused by the novel coronavirus has shut down countries around...

Virtual care and digital health tools are soaring in popularity amid the Covid-19 pandemic. A growing number of patients are forgoing face-to-face visits and instead calling, texting, and video chatting...

Scientists are developing improved forms of genome editing, increasing the number of inherited diseases that CRISPR technology may one day treat. But research veterans have a warning: be prepared for...

Every week, STAT Plus subscribers get access to exclusive conversations with biotech, pharma and health tech leaders. For this month only, thanks to Allscripts, we’re inviting all STAT readers to join in...

From trials to triumph: healing medicine's ailments A multi-year pandemic has brought no end of trials, but also plenty of triumphs. Come for a silo-breaking and solution-focused discussion of the...